Public SEC Form D records
Biotech Series A Form D filings - May 2026
This page lists the 18 matching Form D filings FormDFlow has indexed and tagged from public SEC EDGAR records for Biotech-tagged issuers at a FormDFlow-inferred Series A stage in May 2026 - a filtered subset, not every matching Form D filed, and not a ranked, curated, or recommended selection. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
- Filings
- 18
- Issuers
- 17
- Combined disclosed
- $133.5M
Directory links
Filing records
18 crawlable filing links in this facet.
- Portal Biotechnologies, Inc.May 29, 2026 / Reg D 506(b) / MA$11.9M
- Portal Biotechnologies, Inc.May 29, 2026 / Reg D 506(b) / MA$9.0M
- Klothea Bio, Inc.May 28, 2026 / Reg D 506(b) / FL$10.4M
- StromaGenesis LLCMay 28, 2026 / Reg D 506(b) / PA$10.0M
- TenNor Therapeutics (Suzhou) LtdMay 26, 2026 / Reg D 506(b)$14.7M
- ONCOSYNERGY, INC.May 26, 2026 / Reg D 506(b) / CT$8.2M
- Reprogram Biosciences, Inc.May 26, 2026 / Reg D 506(b) / CA$5.0M
- Reprise Biomedical, Inc.May 21, 2026 / Reg D 506(b) / MN$8.0M
- AB Science S.A.May 18, 2026 / Reg D 506(b)$3.0M
- Remedium Bio Inc.May 18, 2026 / Reg D 506(b) / MA$10.0M
- Cotan Labs, Inc.May 18, 2026 / Reg D 506(b) / CA$10.0M
- Majesty Therapeutics, Inc.May 15, 2026 / Reg D 506(b) / FL$5.0M
- Shuttle Pharmaceuticals Holdings, Inc.May 15, 2026 / Reg D 506(b) / MD$10.0M
- iSpecimen Inc.May 14, 2026 / Reg D 506(b) / MA$2.5M
- EtiraRX, Inc.May 14, 2026 / Reg D 506(b) / TX$3.0M
- NewcelX Ltd.May 13, 2026 / Reg D 506(b)$3.4M
- Federated Biologics Inc.May 13, 2026 / Reg D 506(b)$4.4M
- Lyogenesis Holdings, LLCMay 12, 2026 / Reg D 506(b) / WI$5.0M